Wu Shanshan, Cai Ting, Chen Feng, He Xuefei, Cui Zhihua
Department of Ophthalmology, Ningbo No. 2 Hospital Ningbo 315010, Zhejiang, China.
Ningbo No. 2 Hospital Ningbo 315010, Zhejiang, China.
Int J Clin Exp Med. 2015 Sep 15;8(9):16948-54. eCollection 2015.
Graves ophthalmopathy (GO) is a form of autoimmune thyroid disease commonly found in approximately 25-50% patients with Graves' disease. Both the thyroid-specific genes and immune-modulating genes are involved in susceptibility to GO. However, even though FCRL3 polymorphisms were also autoimmune-associated genes, no study has been performed regarding the association of FCRL3 with GO. Therefore, the objective of the current study was to conduct a basic case-control study in a Chinese population.
Seven SNPs were selected in this case-control study and 577 GD patients and 608 controls were recruited. Odds ratio and 95% confidence interval were used to assess the association between susceptibility of GO and FCRL3 polymorphisms with Stata software (Version 11.0, Stata Corp LP, USA).
The case-control analysis showed that three polymorphisms, FCRL3_3C, FCRL3_5C, FCRL3_6A, were significantly associated with raised risk of GO in a Chinese Han population in the allelic model [OR = 1.28, 95% CI: 1.09-1.51, P = 0.003; OR = 1.26, 95% CI: 1.07-1.48, P = 0.005; OR = 1.25, 95% CI: 1.06-1.47, P = 0.007].
This case-control analysis confirmed that the FCRL3_3, FCRL3_5 and FCRL3_6 polymorphisms were associated with significantly increased risk of GO in a Chinese population.
格雷夫斯眼病(GO)是一种自身免疫性甲状腺疾病,常见于约25%至50%的格雷夫斯病患者中。甲状腺特异性基因和免疫调节基因均与GO易感性有关。然而,尽管FCRL3多态性也是自身免疫相关基因,但尚未有关于FCRL3与GO关联的研究。因此,本研究的目的是在中国人群中进行一项基础病例对照研究。
本病例对照研究选取了7个单核苷酸多态性(SNP),招募了577例格雷夫斯病(GD)患者和608例对照。使用比值比和95%置信区间,通过Stata软件(版本11.0,美国Stata公司)评估GO易感性与FCRL3多态性之间的关联。
病例对照分析显示,在等位基因模型中,FCRL3_3C、FCRL3_5C、FCRL3_6A这三种多态性与中国汉族人群中GO风险升高显著相关[比值比(OR)=1.28,95%置信区间(CI):1.09 - 1.51,P = 0.003;OR = 1.26,95% CI:1.07 - 1.48,P = 0.005;OR = 1.25,95% CI:1.06 - 1.47,P = 0.007]。
本病例对照分析证实,FCRL3_3、FCRL3_5和FCRL3_6多态性与中国人群中GO风险显著增加相关。